4 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow RP-G28: new trials by email Literature Review of RP-G28 trials Research Report on RP-G28
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance RP-G28, Placebos - Lactose Intolerance | Phase 3 | Completed | Ritter Pharmaceuticals, Inc. | 557 | 2018-06-26 | 2019-07-08 |
| Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects RP-G28 - Lactose Intolerance | Phase 1 | Completed | Ritter Pharmaceuticals, Inc. | 14 | 2018-03-09 | 2018-08-08 |
| Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance RP-G28, Placebo - Lactose Intolerance | Phase 2 / Phase 3 | Completed | Ritter Pharmaceuticals, Inc. | 377 | 2016-02-01 | 2018-04-04 |
| Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance RP-G28 or placebo - Lactose Intolerance | Phase 2 | Completed | Ritter Pharmaceuticals, Inc. | 61 | 2011-04-01 | 2011-12-08 |
Ritter Pharmaceuticals, Inc. (4)
United States (4)
Paul G Pearson, PhD (1) · Sharron Gargosky, PhD (1)